Related Experiment Video
Updated: May 21, 2025
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Recurrent transient visual loss in secretory carcinoid tumor
Vivian Paraskevi Douglas1, Shahin Owji2, Mohammad Pakravan3
1Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
Purpose:
We describe a case of a 68-year-old woman who had a biopsy-proven carcinoid of the lung and transient episodes of unilateral and bilateral vision loss presumed to be the result to intermittent serum elevations of vasoactive peptides secondary to an occult carcinoid.
Observations:
A 68-year-old female with history of carcinoid tumor of the lung presented with multiple recurrent and alternating unilateral and bilateral transient vision loss (TVL) which were increasing in frequency over a period of one month. Ophthalmologic examination was unremarkable. Further investigations were significant for elevated levels of serum chromogranin A. Positron emission tomography (PET) showed no recurrent or metastatic carcinoid tumor until after 11 months of persisting symptoms along with increased serum chromogranin A levels where three carcinoid tumorlets were detected in the left lower pulmonary lobe.
Conclusions And Importance:
Clinicians should be aware that TVL can be a manifestation of the vasoactive secretory products in patients with history of carcinoid tumor.
Related Concept Videos
01:25Glaucoma: Overview
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...